Relapsed/Refractory

The term “relapsed” refers to disease that reappears or grows again after a period of remission.

The term “refractory” is used to describe when the lymphoma does not respond to treatment (meaning that the cancer cells continue to grow) or when the response to treatment does not last very long.

Central Nervous System (CNS) involvement at diagnosis of Burkitt lymphoma is recognized as the strongest risk factor for relapse; therefore, recommended treatment regimens include treatment to protect the CNS, which may be given intrathecally (injected into the spinal fluid).

To learn more about primary central nervous system (CNS) lymphoma, visit the CNS Lymphoma page.

Learn More

To learn more about Burkitt lymphoma, view the Other Aggressive B-Cell Lymphoma Guide. Want to talk to someone? For answers to lymphoma-related questions 
and resources, contact our Lymphoma Resource Center at (800) 500-9976 or [email protected].